Fmoc-FFC
Fmoc-FFC is a competitive MBL (NDM-1, VIM-2, and IMP-1) inhibitor with Ki values of 2.3, 6.0, and 7.1 μM, respectively. Fmoc-FFC alone has no antibacterial activity, but acts synergistically with Meropenem (HY-13678) to restore antibacterial activity against MBL/NDM-1-producing E. coli. Fmoc-FFC supports cell-cell adhesion and can serve as a scaffold for cell culture growth. Fmoc-FFC can be used in research on systemic infections caused by NDM-1-producing E. coli.
For research use only. We do not sell to patients.
- Formula: C36H35N3O5S
- Molecular Weight:621.75
-
Storage:
Please store the product under the recommended conditions in the Certificate of Analysis.
All Beta-lactamase Isoforms
More
Biological Activity
Description
In Vitro
Fmoc-FFC (0-600 μM; 15 min) inhibits recombinant NDM-1, VIM-2, and IMP-1 with Ki values of 2.3, 6.0, and 7.1 μM, respectively[1].
Fmoc-FFC (1-10 μM; 5 min) competitively inhibits NDM-1 independently of zinc deprivation[1].
Fmoc-FFC (up to 128 μg/mL; 24 h) maintained >80% viability in HEK-293T and HUVEC cells[1].
Fmoc-FFC (up to 256 μg/mL; 1 h) caused <5% hemolysis of rabbit erythrocytes[1].
Fmoc-FFC (0-32 μg/mL; 16-20 h) combined with Meropenem (HY-13678) produced an inhibition zone >15 mm against MBL-producing Escherichia coli[1].
MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only. Further protocols information, click here.
-
Cell Line:HEK-293T and HUVEC human cell lines
-
Concentration:up to 128 μg/mL (Fmoc-FFC, serial dilutions)
-
Incubation Time:24 h
-
Result:Cell viability remained above 80% even at concentrations up to 128 μg/mL.
In Vivo
Fmoc-FFC (10 mg/kg; i.p.; every 12 h; four doses) plus meropenem (10 mg/kg) achieves 100% survival and reduces organ bacterial burden in a lethal murine systemic infection model[1].
MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.
-
Animal Model:BALB/c (male, 6-8 weeks, 16-18 g)[1]
-
Dosage:10 mg/kg
-
Administration:i.p.; every 12 h; four doses
-
Result:Fmoc-FFC monotherapy (10 mg/kg) group: all mice succumbed to infection within 48 h (0% survival).
-
Animal Model:BALB/c (male, 6-8 weeks, 16-18 g)[1]
-
Dosage:10 mg/kg plus meropenem 10 mg/kg
-
Administration:i.p.; every 12 h; four doses
-
Result:Fmoc-FFC (10 mg/kg) plus meropenem (10 mg/kg) resulted in 100% survival over 96 h.
The combination produced a multi-log reduction in bacterial counts in the liver, spleen, and kidneys compared with meropenem alone.
Chemical Information
-
Molecular Weight 621.75
-
Formula C36H35N3O5S
-
SMILES
O=C(N[C@@H](CC1=CC=CC=C1)C(N[C@@H](CS)C(O)=O)=O)[C@@H](NC(CC2C3=C(C=CC=C3)C4=C2C=CC=C4)=O)CC5=CC=CC=C5
-
Shipping
Room temperature in continental US; may vary elsewhere.
-
Storage
Please store the product under the recommended conditions in the Certificate of Analysis.
Protocols
-
Research Protocol for Infectious Diseases
Infectious-disease experiments test how pathogens interact with host barriers, innate immune receptors, inflammatory signaling, pathogen replication, and tissue injury; pattern-recognition receptors such as TLRs, RIG-I-like receptors, NOD-like receptors, and inflammasomes detect microbial molecules and activate NF-κB, interferon, and cytokine responses. The central hypothesis is that infection severity reflects the balance between pathogen burden and host response: protective inflammation restricts pathogen growth, whereas excessive or mislocalized inflammation contributes to tissue damage and disease phenotype. Unresolved questions include which host pathways are protective versus pathogenic, why some infection models fail to translate to human disease, and which combined readouts best predict clinically relevant infection outcomes.
-
Bacterial live/dead nucleic-acid viability staining
The LIVE/DEAD bacterial viability staining method is based on differential permeability of nucleic-acid-binding fluorescent dyes, most commonly SYTO 9 and propidium iodide (PI), which enables discrimination of bacterial populations with intact versus compromised cytoplasmic membranes. SYTO 9 penetrates both intact and damaged bacterial membranes and binds nucleic acids to produce green fluorescence, whereas propidium iodide penetrates only cells with compromised membranes and fluoresces red while also reducing SYTO 9 signal through competitive binding and fluorescence interactions. The resulting fluorescence pattern is interpreted as a proxy for membrane integrity, which is widely used as an indicator of bacterial viability in microscopy, flow cytometry, and spectroscopic platforms. However, mechanistic studies show that SYTO 9 and PI interactions involve displacement and fluorescence resonance energy transfer effects, which can influence signal interpretation depending on dye ratios a
Purity & Documentation
References
Calculators
Concentration (start) × Volume (start) = Concentration (final) × Volume (final)